Unfortunately this type of trading has been going on from day...

Unfortunately this type of trading has been going on from day dot, all small caps are the same, cheap, little profits to be made, Rinse Repeat, Orthocell is a day traders cash cow, these guys are over the moon with 2 / 5% gains, sell and repeat

Very hard to break the cycle, I thought approvals might have broken the day traders cycle, but here we are. We have dropped over twelve cents for absolutely no reason other than a profit take, end of financial year sell down

Management have put Orthocell in a great position to ready itself for partnership and revenue. I’m watching a few biotech companies that are 2-10 times Orthocells worth, who are still doing stage 1, 2 trials, but big institutional investment hold the majority of their shares.

Orthocell is ready for a price correction when the first partnership is formed in the US of A, until than it’s just Rinse, Repeat